• GDS Medtech - Reflux Band

diagnostic and treatment innovations for the spectrum of ear, nose and throat disorders. 

Our product portfolio continues to evolve to include the very latest in diagnostic and medical treatment technology.

We are delighted to bring several new products to our portfolio in 2018 with the aim of assisting ENT clinicians in their surgical and outpatient practice.  Products released this autumn include ChondroBLANK, a new biomaterial for maxillofacial reconstruction, the NasoNeb Sinus Delivery System and Reflux Band for the treatment of laryngopharyngeal reflux (LPR).

ChondroBLANK represents an alternative treatment for patients requiring replacement cartilage where the alternative would be a synthetic or harvested solution.  This new material benefits both the clinician and the patient.  ChondroBLANK is reliable in its availability as a material, flexible to adapt to surgical demands and enables an alternative option to patients that affords an improved process of recovery. Read below for more details or visit the ChondroBLANK product page for detailed information and to view the product brochure.

ChondroBLANK (new) – a biomaterial for bone augmentation and facial reconstruction


ChondroBLANK is a biological graft derived from equine nasal septum. The graft is made of cartilage without perichondrium, which is then chemically processed and sterilized. The main difference with the synthetic materials available on market is that Chondroblank is smooth, resistant, elastic and at the same time extremely malleable and tailorable. These unique features allow to get any shape and even different thicknesses in a single piece.

Primary applications for ChondroBLANK in maxillofacial surgery:

  • Orbital floor and orbital walls reconstruction
  • Reinforcement of the nasal cartilage structures
  • Increase projection of the facial bones in various areas (cheekbones, forehead, chin).

Visit the new ChondroBLANK product page and view the new ‘see inside’ brochure.


WatchPAT Central PLUS – enables specific identification of Central Sleep Apnea (CSA).

WatchPAT Central PLUS

Until now, WatchPAT has been clinically proven to detect all types of apnea events.  The new WatchPAT Central PLUS enables specific identification of Central Sleep Apnea (CSA).

With this new capability, patients suspected of having sleep apnea can be diagnosed more specifically with an exceptionally easy to use, automated and accurate WatchPAT HST device and benefit from an optimized treatment. Visit the new WatchPAT Central PLUS page for product details.


NasoNebSinus Therapy System

NasoNeb Sinus Therapy System
The new, next generation NasoNeb™ Sinus Therapy System offers the same effective treatment in a single nostril delivery system.

NasoNeb™ further optimises the delivery of medication to the nasal and sinus mucosa  using a new single nostril delivery system.  NasoNeb™ achieves improved efficacy by combining the correct particle size, airflow and fluid volume to ensure prescribed medication is effective, reaching only the nasal and sinus areas.

Visit the NasoNeb® page for further product details or visit www.nasoneb.co.uk if you are a patient looking to find more information and order a system.




Visit the new NasoNeb online patient portal.

For details on how the NasoNeb system can help you with ordering facility.
NasoNeb Patient Website